Wells Fargo Reiterates Overweight Rating on Dianthus Therapeutics (DNTH)

March 19, 2026 5:23 AM

Wells Fargo reiterated an Overweight rating and $135.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found